Mercer Global Advisors Inc United Therapeutics Corp Transaction History

Mercer Global Advisors Inc

  • $39.5 Billion
  • Q2 2024

A detailed history of Mercer Global Advisors Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 13,918 shares of UTHR stock, worth $5.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,918
Previous 11,905 16.91%
Holding current value
$5.6 Million
Previous $2.74 Million 62.08%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$228.26 - $319.04 $459,487 - $642,227
2,013 Added 16.91%
13,918 $4.43 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $79,456 - $94,065
-377 Reduced 3.07%
11,905 $2.74 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $28,149 - $33,659
131 Added 1.08%
12,282 $2.7 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $473,841 - $555,312
2,237 Added 22.56%
12,151 $2.75 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $191,442 - $217,379
933 Added 10.39%
9,914 $2.19 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $150,370 - $194,976
706 Added 8.53%
8,981 $2.01 Million
Q4 2022

Feb 08, 2023
SELL
$205.95 - $280.43 $8,032 - $10,936
-39 Reduced 0.47%
8,275 $2.3 Million
Q3 2022

Nov 15, 2022
SELL
$203.3 - $244.17 $18,703 - $22,463
-92 Reduced 1.09%
8,314 $1.74 Million
Q2 2022

Aug 10, 2022
SELL
$174.81 - $241.14 $2,272 - $3,134
-13 Reduced 0.15%
8,406 $1.98 Million
Q1 2022

May 10, 2022
SELL
$166.16 - $213.96 $213,515 - $274,938
-1,285 Reduced 13.24%
8,419 $1.51 Million
Q4 2021

Feb 04, 2022
BUY
$184.32 - $216.08 $96,583 - $113,225
524 Added 5.71%
9,704 $2.1 Million
Q3 2021

Nov 10, 2021
BUY
$179.86 - $214.88 $60,972 - $72,844
339 Added 3.83%
9,180 $1.69 Million
Q2 2021

Aug 10, 2021
BUY
$170.47 - $211.93 $147,967 - $183,955
868 Added 10.89%
8,841 $1.59 Million
Q1 2021

May 11, 2021
BUY
$153.94 - $174.85 $444,732 - $505,141
2,889 Added 56.83%
7,973 $1.33 Million
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $220,956 - $329,232
2,169 Added 74.41%
5,084 $772,000
Q3 2020

Dec 10, 2020
BUY
$99.9 - $121.13 $21,178 - $25,679
212 Added 7.84%
2,915 $294,000
Q2 2020

Aug 10, 2020
BUY
$92.74 - $125.82 $250,676 - $340,091
2,703 New
2,703 $327,000
Q1 2020

May 18, 2020
SELL
$79.39 - $115.35 $610,985 - $887,733
-7,696 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $62,804 - $76,462
802 Added 11.63%
7,696 $678,000
Q3 2019

Nov 12, 2019
BUY
$74.85 - $85.99 $156,810 - $180,149
2,095 Added 43.65%
6,894 $549,000
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $31,184 - $49,532
410 Added 9.34%
4,799 $375,000
Q1 2019

Apr 23, 2019
BUY
$107.15 - $126.84 $470,281 - $556,700
4,389 New
4,389 $515,000

Others Institutions Holding UTHR

# of Institutions
645
Shares Held
45M
Call Options Held
368K
Put Options Held
414K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email